Arthneeti
MH

Manipal Health Enterprises Ltd

Q2 FY27Healthcare Services

Manipal Health Enterprises Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Manipal Health Enterprises Ltd Q2 FY27 key numbers

Revenue
Outpatient (OP) volumes for Q2 FY27: 1.74 million, up 27.2% year-on-year.

As stated in Manipal Health Enterprises Ltd's Q2 FY27 investor presentation · published 13 Nov 2026. Reported figures, not investment advice.

Based on Manipal Health Enterprises Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹677
Market cap₹88.9K Cr
P/E100.5

The short version

Revenue from operations for Q2 FY27: INR 3,399 crore, up 37.3% year-on-year (vs INR 2,475 crore in Q2 FY26). Q2 FY27 EBITDA: INR 882.2 Cr, up 29.8% YoY (from INR 679.8 Cr in Q2 FY26).

From Manipal Health Enterprises Ltd's Q2 FY27 earnings-call transcript · updated 13 Nov 2026.

How did Manipal Health Enterprises' revenue grow in the September 2026 quarter?

  • Revenue from operations for Q2 FY27: INR 3,399 crore, up 37.3% year-on-year (vs INR 2,475 crore in Q2 FY26).
  • Inpatient (IP) volumes for Q2 FY27: 169,000, up 35.0% year-on-year (vs 125,000 approx. in Q2 FY26).
  • Outpatient (OP) volumes for Q2 FY27: 1.74 million, up 27.2% year-on-year.
  • Occupancy for Q2 FY27: 70.1%, increased 160 basis points YoY from 68.5%.

2 more points from Manipal Health Enterprises Ltd's call on revenue

Create a free account to keep reading this call

What happened to Manipal Health Enterprises' margins in Q2 FY27?

Q2 FY27 EBITDA: INR 882.2 Cr, up 29.8% YoY (from INR 679.8 Cr in Q2 FY26)

Locked: what Manipal Health Enterprises Ltd said on margins

Also locked on this page: fundraising, order book

Free account, 30 seconds. No card needed.

What capex is Manipal Health Enterprises planning?

  • Advanced oncology equipment installed at Nashik (H1 FY27).
  • AI-assisted neuro biplane Cath Lab system added at Mukundpur (H1 FY27).
  • Orthopedic robots deployed at Patiala, Vijayawada, and Pune Baner (H1 FY27).
  • AI-enabled Cath Lab (Allia, GE USA) added at Old Airport Road (H1 FY27).
  • Addition of high-end LINAC and PET CT at MH Nashik (H1 FY27).
  • Expansion includes 19 LINACs, 59 Cath Labs, 16 PET CTs, 27 Orthopedic & Spine Surgical Robots, 44 MRI units, 24 Soft Tissue Robots, 6 Gamma Cameras.
  • New hospital launched: 300 licensed beds at Manipal Hospital @ Electronic City, Bengaluru (Q2 FY27).

2 more points from Manipal Health Enterprises Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
1Health X Platform
Rev 1Mar 1
2Chandan Healthca
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Manipal Health Enterprises raising money or cutting debt?

It references borrowing through Non-Convertible Debentures (NCDs) taken for the Sahyadri acquisition, with…

Locked: what Manipal Health Enterprises Ltd said on fundraising

Also locked on this page: margins, order book

Free account, 30 seconds. No card needed.

How big is Manipal Health Enterprises' order book?

See what Manipal Health Enterprises Ltd said on order book & pipeline — free account, 30 seconds.

Manipal Health Enterprises Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27

Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹3.1K Cr, net profit ₹243 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

More Q2 FY27 results in Healthcare Services

All Q2 FY27 results | Healthcare Services rankings

Continue your research

What Manipal Health's management said in earlier quarters

Others in Healthcare Services this season

  • Park Medi World (Q2 FY27)

    other income) was ₹5,110 mn, a 25% YoY increase from ₹4,102 mn in Q2 FY’26. Key investor presentation takeaways from Park Medi World Ltd's Q2 FY27 investor pres

  • Gaudium IVF (Q2 FY27)

    Revenue from operations for quarter ended September 30, 2026: ₹3,741.11 lakhs (Consolidated), ₹2,805.68 lakhs (Standalone) . Key results statement takeaways fro

  • Nephro Care (Q2 FY27)

    Income from IPD Services: ₹1,915.45 Lakhs . Key results statement takeaways from Nephro Care India Ltd's Q2 FY27 results statement — and how it ranks against se

  • Lotus Eye Hospit (Q2 FY27)

    1,303.84 lakhs for the quarter ended September 30, 2025, indicating a year-on-year increase of approximately 36%. Key results statement takeaways from Lotus Eye

Compare:vs Apollo Hospitalsvs Max Healthcarevs Aster DM Quality

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Manipal Health Enterprises Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Manipal Health Enterprises Ltd Q2 FY27 results?

Revenue from operations for Q2 FY27: INR 3,399 crore, up 37.3% year-on-year (vs INR 2,475 crore in Q2 FY26). Q2 FY27 EBITDA: INR 882.2 Cr, up 29.8% YoY (from INR 679.8 Cr in Q2 FY26).

What is Manipal Health Enterprises Ltd share price analysis?

Manipal Health Enterprises Ltd currently shows a neutral. The stock trades at a P/E of 100.5 with a market cap of ₹88,944 Cr. Investors should review the full earnings analysis for detailed insights.

Is Manipal Health Enterprises Ltd planning capital expenditure?

Advanced oncology equipment installed at Nashik (H1 FY27).

Keep Manipal Health Enterprises Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.